Atorvastatin calcium and Failure to thrive - a phase IV clinical study of FDA data

Summary:

Failure to thrive is reported as a side effect among people who take Atorvastatin calcium (atorvastatin calcium), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Gabapentin, and have Diabetes.

The phase IV clinical study analyzes which people have Failure to thrive when taking Atorvastatin calcium. It is created by eHealthMe based on reports of 72,753 people who have side effects when taking Atorvastatin calcium from the FDA, and is updated regularly.

What is Atorvastatin calcium?

Atorvastatin calcium has active ingredients of atorvastatin calcium. It is often used in high blood cholesterol. eHealthMe is studying from 77,309 Atorvastatin calcium users. Check the latest studies of Atorvastatin calcium.

What is Failure to thrive?

Failure to thrive (inadequate weight gain and physical growth in children) is found to be associated with 771 drugs and 1,168 conditions by eHealthMe. Check the latest studies of Failure to thrive.

On Jul, 28, 2026

72,753 people reported to have side effects when taking Atorvastatin calcium.
Among them, 14 people (0.02%) have Failure to thrive.

Could Atorvastatin calcium cause Failure to thrive?

Among these 14 people:

How long have people been on Atorvastatin calcium when they have Failure to thrive? *

What is the gender of people who have Failure to thrive when taking Atorvastatin calcium? *

female: 71.43 %
male: 28.57 %

What is the age of people who have Failure to thrive when taking Atorvastatin calcium? *

What are other drugs people take besides Atorvastatin calcium? *

What are other side effects people have besides Failure to thrive? *

Anaemia (lack of blood): 5 people, 35.71%
Dehydration (dryness resulting from the removal of water): 4 people, 28.57%
Urinary Tract Infection: 4 people, 28.57%
Dyspnea (difficult or laboured breathing): 4 people, 28.57%
Hypocalcaemia (levels of calcium in blood serum are abnormally low): 3 people, 21.43%
Hyperkalemia (damage to or disease of the kidney): 3 people, 21.43%
Diarrhea: 3 people, 21.43%
Colitis (inflammation of colon): 3 people, 21.43%
Pneumonia: 3 people, 21.43%
Hyponatremia (abnormally low level of sodium in the blood; associated with dehydration): 3 people, 21.43%

What are the existing conditions these people have? *

Appetite Disorder (abnormal eating habits): 3 people, 21.43%
Pain: 3 people, 21.43%
Oropharyngeal Pain: 3 people, 21.43%
Non-Small Cell Lung Cancer Metastatic (type of epithelial lung cancer spreads to other parts): 3 people, 21.43%
Nausea And Vomiting: 3 people, 21.43%
Nausea (feeling of having an urge to vomit): 3 people, 21.43%
Cough: 3 people, 21.43%
Diabetes: 3 people, 21.43%
Stress And Anxiety: 2 people, 14.29%
Constipation: 2 people, 14.29%

* Approximation only. Some reports may have incomplete information.

Do you take Atorvastatin calcium and have Failure to thrive?

- Check whether Failure to thrive is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Atorvastatin calcium:

Atorvastatin calcium (77,309 reports)

Browse all side effects of Atorvastatin calcium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Failure to thrive:

Failure to thrive (771 drugs)

Browse all the conditions that are associated with Failure to thrive:

Failure to thrive (1,168 conditions)

Related publications that referenced our studies

Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .
Proti? D, Balti? S, Stupar N, Pavlov-Dolijanovi? S, Mugo?a S, Todorovi? Z, "A case of myositis with immunological background associated with statin use", Open Medicine, 2014 Oct .
Goldie MP, "Atorvastatin: a new treatment for periodontal disease?", , 2012 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on atorvastatin calcium (the active ingredients of Atorvastatin calcium) and Atorvastatin calcium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.